HB1482 creates a new regulatory framework for manufactured hemp products in Hawaii. Beginning January 1, 2026, distributors and retailers of manufactured hemp products must obtain a certificate of registration from the Department of Health, pay application and renewal fees, display the certificate at their place of business and online, and comply with registry and recordkeeping requirements. The bill also defines key terms such as “manufactured hemp product distributor,” “manufactured hemp product retailer,” “registry,” and “tincture,” and exempts certain products, including topically applied products, from the registration requirement.
The bill also creates the offense of unlawful hemp distribution or retailing for entities that recklessly fail to register while selling or handling hemp products, with misdemeanor penalties and a class C felony for repeat offenses within five years. It grants the Department of Health and the Attorney General inspection authority over businesses dealing in hemp products, authorizes seizure and forfeiture of noncompliant products, and adds nuisance-abatement and unfair-and-deceptive-practices remedies. In addition, it bars the sale of tinctures to persons under 21, requires age verification for purchasers who appear under 27, and imposes fines and forfeiture for violations involving underage possession or purchase.
The bill’s impact on state law is broad: it amends Chapter 328G governing hemp processing, expands enforcement tools in section 328G-6, updates the use of the Hawaii hemp processing special fund, and assigns the Office of Medical Cannabis Control and Regulation responsibility for administering the hemp processors program. It also amends the nuisance statute to make places used for violating the hemp distribution offense subject to abatement. Overall, the measure strengthens state oversight of the hemp retail market and ties hemp product compliance to both administrative and criminal enforcement.
The general sentiment reflected in the voting history appears largely supportive, with the bill advancing through multiple Senate committees, Ways and Means, Judiciary, and then conference committees with unanimous or near-unanimous votes. The pattern suggests broad agreement on the need for tighter regulation and enforcement of hemp product sales. No committee transcripts were provided, so there is no direct record of floor or committee debate to indicate detailed public testimony or member concerns.
The main points of contention likely center on the scope of regulation and enforcement: mandatory registration fees, inspection authority, seizure and forfeiture powers, criminal penalties for unregistered sales, and the under-21 restrictions on tinctures. The bill also distinguishes between hemp processors and other hemp product sellers, which may affect businesses differently depending on their existing permits and sales channels. Because the available record contains no discussion transcripts, specific objections cannot be attributed to named legislators or stakeholders.
HB1482 amends Hawaii Revised Statutes Chapter 328G to establish a registration system for manufactured hemp product distributors and retailers, create new offenses and penalties for unregistered hemp sales, expand inspection and seizure authority, and add age-based restrictions for tinctures. It also revises related enforcement, nuisance-abatement, and special-fund provisions, and assigns the Office of Medical Cannabis Control and Regulation a role in administering the hemp processors program. The bill therefore increases state oversight of hemp product commerce and adds both administrative and criminal consequences for noncompliance.
The voting history shows strong support across Senate committees and conference committees, with most votes unanimous and one committee vote 4-1. That pattern indicates the bill was generally viewed favorably as a consumer-protection and enforcement measure. No committee transcripts were available, so the record does not show detailed debate, but the legislative trajectory suggests broad consensus on the need for tighter hemp regulation.
The likely areas of disagreement are the bill’s regulatory burden and enforcement powers. Businesses affected by the new registry may object to fees, display requirements, inspections, and the possibility of suspension, revocation, seizure, forfeiture, and nuisance-abatement actions. The tincture provisions, especially the ban on sales to persons under 21 and mandatory ID checks, may also be contentious for retailers and some hemp industry stakeholders. Because no transcripts were provided, these concerns are inferred from the bill’s structure rather than from recorded testimony.